Indivior Announces New Study Data in Patients with Moderate to Severe Opioid Use Disorder (OUD) at the 50th ASAM Annual Conference - BioSpace

Submitted by Anonymous (not verified) on Sat, 04/06/2019 - 12:33

Indivior Announces New Study Data in Patients with Moderate to Severe Opioid Use Disorder (OUD) at the 50th ASAM Annual Conference  BioSpacePublished: Apr 06, 2019. Injecting opioid users may benefit from higher maintenance dose of SUBLOCADE™ (buprenorphine extended-release), ...